XXXX in @entity2590 : a clinicopathological study.

@entity1 @entity548 @entity1423 @entity2590 @entity2915 @entity715 @entity855
Forty-eight @entity1 with @entity2590 and a platelet count greater than 80 x 10(9)/L were the subjects of a study of platelet function. A whole-blood platelet lumi-aggregometer was used for simultaneous measurement of @entity1423 by the impedance method and of @entity855 -dense granule release. The results were correlated with skin @entity548 time and episodes of clinical @entity548 or @entity715 . Thirty-five @entity1 had at least 1 abnormal result indicating @entity1423 ; 7 @entity1 had mixed @entity1423 and @entity2915 ; and 4 @entity1 had @entity2915 . Only 2 @entity1 had normal results. There was good correlation between @entity1423 and prolonged skin @entity548 time (P = .005); however, several @entity1 with @entity1423 had normal skin @entity548 times. This finding suggested that whole-blood @entity1423 studies may be more sensitive than @entity548 time in identification of @entity1 at risk of @entity548 . Clinical @entity548 was frequent (32 @entity1 ) in this cohort despite platelet counts greater than 100 x 10(9)/L. This finding indicated @entity1423 was clinically important. In contrast, only 2 of the 13 @entity1 with @entity715 events had evidence of @entity2915 , suggesting that other clinical factors are probably more important determinants of @entity715 . These observations confirm that @entity1423 is common in @entity1 with @entity2590 and suggest a useful role for routine whole-blood @entity1423 studies to identify @entity1 at risk of @entity548 .
